Clinical trial
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease
NCT00250393 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00250393 |
|---|---|
| Title | A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease |
| Official title | Placebo-Controlled , Crossover , Double-Blind Study of KW-6002(Istradefylline) in the Treatment of Parkinson's Disease. [Monotherapy] |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Istradefylline (KW-6002) |
| Enrollment | 64 |
| Start date | Nov 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Nov 8, 2005 |
| Last update posted | Aug 29, 2012 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: